Research Article |
Corresponding author: Syafruddin Ilyas ( syafruddin6@usu.ac.id ) Academic editor: Rumiana Simeonova
© 2023 Cheryl Grace Pratiwi Rumahorbo, Syafruddin Ilyas, Salomo Hutahaean, Cut Fatimah Zuhra, Putri Cahaya Situmorang.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Rumahorbo CGP, Ilyas S, Hutahaean S, Fatimah Zuhra C, Situmorang PC (2023) Oral chronic toxicity test of nano herbal Phaleria macrocarpa. Pharmacia 70(2): 411-418. https://doi.org/10.3897/pharmacia.70.e106744
|
Extracts of Phaleria macrocarpa have been used for years in traditional medicine and have been evaluated scientifically as well. This study aimed to evaluate the chronic toxicity level of nano herbal Phaleria macrocarpa and its effect on the changes in hematology, biochemistry, electrolytes, and organ histopathology. High Energy Milling (HEM) produced nano herbal Phaleria macrocarpa. By giving nano herbal Phaleria macrocarpa at doses of 300, 600, and 900 mg/kg BW for 56 days, the mice’s blood was collected for the hematological and electrolyte parameters. The kidney and liver were assessed for biochemical parameters. As a result, the nano herbal Phaleria macrocarpa affected the histopathological organs, hematological, biochemical, and electrolyte parameters at an appropriate dose of 300–600 mg/kg BW. The maximum period of the administration this herbal medicine is one month. Therefore, with the correct dose and period of administration, this plant can be used as herbal medicine in the future.
Nanoherbal, Phaleria macrocarpa, Chronic toxicity
As a tropical country, Indonesia has high biodiversity, including plants that can be used for medicine. Phaleria macrocarpa, commonly known as God’s crown or Mahkota Dewa, is one of the Indonesian medicinal plants with a million benefits. This native Indonesian plant that grows in Papua is believed to be able to treat various diseases. The extract of Phaleria macrocarpa’s fruit has been proven to have anti-cancer, anti-diabetic, anti-gout, and anti-hepatitis properties. The main content of Phaleria macrocarpa is phalerin (content up to 9.52%) (
The effectiveness of the Phaleria macrocarpa extract is also influenced by the size of the herbal particles that penetrate the cell membrane. Therefore, modifying particle size to nano size is expected to increase the effectiveness of the herbal. In addition to particle size, the accuracy of the dose is also one of the effectiveness determinants of herbal medicine. The acute toxicity test of the LD50 nano herbal Phaleria macrocarpa method has been carried out in previous studies, which found that the LD 50 nano herbal Phaleria macrocarpa was 1g/kg BW ± 0.075 (
5 kg of Phaleria macrocarpa fresh fruit were purchased from the traditional market of Medan City, Indonesia. First, the fresh Phaleria macrocarpa was washed using flowing water. Then, the Phaleria macrocarpa was air-dried in a room without exposure to direct sunlight for three weeks. Next, the dried Phaleria macrocarpa was ground to obtain a coarse powder. Finally, 2.5 kg of Phaleria macrocarpa coarse powder was processed into nanoparticles using a high-energy milling tool with HCl 2 M activator solution (Tokyo, Japan). The milling was done with a mass ratio of 1:20 (powder to ball milling mass) and milling times of 3, 6, and 9 hours until producing the nano herbal flesh fruit Phaleria macrocarpa (
Twenty-four male mice (Mus musculus) aged between 2.5–3 months with an average body weight of 25–30 g and without anatomical defects were obtained from animal cages at the Faculty of Mathematics and Science, Universitas Sumatera Utara, Indonesia. They were divided into four groups consisting of 3 test groups (T1, T2, T3) and one control group (C). Before starting the experiment, all mice were acclimatized for seven days to accustom the animals to the experimental environment. Food and drink are provided in moderation. The mice used were healthy and did not experience a change in body weight of more than 10%, and visually showed normal behavior. The dose of the test preparation given to the test animals was determined based on previous research, which showed that the LD50 value was 1 g/kg BW. Therefore, the doses of the test preparations given to the test animals were 300 (T1), 600 (T2), and 900 (T3) mg/kg BW. The test preparations were given orally with a frequency of once a day for 56 days (
The hematological analysis was conducted using Hematology Analyzer Merk Wiener Lab at North Sumatra Regional Health Lab. Complete blood counts were tested to measure the physiological effect of the herbal. Liver and kidney function were analyzed by COBAS 6000, and blood electrolytes were analyzed by Cobas b 221 POC system.
The liver, lungs, kidney, and heart specimens were covered in paraffin wax over two hours at 60–700 degrees Celsius. The paraffin blocks were cut with a microtome about 5–7 µm thickness, molded, and then frozen. The organ cuts were then placed on a heating surface between 56–58 °C for about ten seconds to stretch and adhere to the slide. Adjustments were made to avoid folded tissues. Further, hematoxylin and eosin stains were carried out. The tissue was soaked for twelve minutes in a xylene solution. After five minutes of immersion in 70%, 80%, 90%, and 100% ethanol, the tissue was dehydrated by washing in flowing water. After 5 minutes in the hematoxylin solution, the samples were washed under the water flow, stained with eosin, and then buried in 70%, 80%, 90%, and 100% ethanol for 10 minutes. In the last step, the samples were soaked in xylene for 12 minutes before being examined at 40× magnification under the microscope.
The statistical, qualitative, and intervention analyses use Microsoft Excel 2021 and SPSS 25. Analysis of variance (ANOVA) was used to determine whether there were any significant differences in histopathological assessment and physiological parameters of the blood, kidney, and liver at various concentrations of nano herbal flesh fruit Phaleria macrocarpa. The data were tested at a 95% confidence interval, with the result considered significant if the p <0.05. The least significant difference (LSD) test was used to determine which treatment was statistically significant compared to the control.
Fig.
Meanwhile, other parameters such as AST, ALP, total protein, and serum albumin showed a significant increase in the last days of herbal administration or at high doses, as in the ALP parameter. High ALP values only occurred at T3 from day 14th to day 56th, while the other treatment groups did not increase significantly. Based on this finding, it can be concluded that administering nano herbal Phaleria macrocarpa can increase the values of several biochemical parameters in the liver. That value is still within the normal range. However, it is recommended that the administration of these nano-herbs be at most one month. This finding is supported by a literature review conducted by
Fig.
Other blood test results demonstrated no significant difference between the treatment and control groups. Although insignificant, there was a change in the value of all types of blood parameters in the administration of nano-herbal Phaleria macrocarpa. Through this discovery, it can be concluded that the administration of nano-herbal Phaleria macrocarpa did not significantly affect the physiological changes in the blood of the animal test up to day 56th of exposure. This finding was confirmed by previous findings by
Fig.
Fig.
In Table
Group | Hepatocytes (400×) | Degeneration of the parenchyma (%) | Hydropic degeneration (%) | Necrosis (%) |
---|---|---|---|---|
Control | 376.23±4.24 | 22.32±2.44 | 21.12±1.25 | 2.82±2.44 |
T1 | 382.07±7.21 | 20.24±2.71 | 16.61±2.72 | 2.72±1.07 |
T2 | 111.57±6.23* | 44.34±2.63* | 45.22±3.11* | 8.77±3.80* |
T3 | 78.17±9.22** | 66.73±2.92* | 52.11±1.21* | 12.12±3.62* |
Lung histology evaluates three criteria: inflammation, parenchymal degeneration, and the lumen narrowing of the alveolar. The level of inflammation was: average/0, light/1, medium/2, severe/3. Parenchymal degeneration level was: average/0, 0–30% damage/1, 31–60% damage/2, >61% damaged/3. Narrowing of the alveolar lumen level was 0; average/0, 0–30% narrowing/1, 31–60% narrowing/2, > 61% narrowing/3. Level 1 inflammation, level 1 parenchymal damage, and level 2 alveolar lumen narrowing occurred in the control group, as shown in Fig.
The inflammation structure was linked to the fact that the terminal of bronchioles, alveolar tubes, and adjacent alveoli were the locations of the most significant inhaled tiny particle (
Macrophages, neutrophils, and eosinophils detoxify free radicals. Therefore, an excessive rise in the airway might lead to the migration of neutrophils, macrophages, and eosinophils, triggering an inflammatory response and increasing death cells (
The histopathological characteristics of the renal system were evaluated using the following assessment method.
According to Table
Treatments | Alveolar inflammation | Parenchymal damage (%) | Narrowing of the lumen alveolar |
---|---|---|---|
Control | 1 ± 0.00 | 1 ± 0.00 | 2 ± 0.00 |
T1 | 0 ± 0.00 | 0 ± 0.00 | 1 ± 0.00 |
T2 | 2 ± 0.00 | 2 ± 0.00 | 3 ± 0.00 |
T3 | 1 ± 0.00 | 2 ± 0.00 | 2 ± 0.00 |
Assessed tissue | Description | Score |
---|---|---|
Tubular | No damage | 0 |
<25% loss of the brush border, basement membrane intact. | 1 | |
>25% loss of the brush border, basement membrane thickening | 2 | |
<60% necrotic tubular cells | 3 | |
>60% necrotic tubular cells | 4 | |
Endothelium | Normal | 0 |
Endothelial cell swelling | 1 | |
Endothelial dysfunction | 2 | |
Loss of endothelial | 3 | |
Glomerulus | Normal | 0 |
Thickening of capsule Bowman | 1 | |
The juxtaglomerular apparatus retracts | 2 | |
Glomerular fibrosis | 3 | |
Tubulointerstitial | Normal | 0 |
Inflammation (<25% tissue bleedings) | 1 | |
Necrosis (25% tissue bleeding) | 2 | |
60% Necrosis | 3 | |
>60% Necrosis | 4 |
Treatments | Tubular | Glomerulus | Endothelium | Tubulointerstitial |
---|---|---|---|---|
Control | 0 | 1 | 1 | 1 |
T1 | 0 | 0 | 0 | 1 |
T2 | 2 | 2 | 1 | 2 |
T3 | 1 | 1 | 2 | 1 |
The renal system plays a vital role in sustaining body stability by managing the body’s fluids, ions, and acidic substances by conducting filtering blood (
Table
Group | Normal cardiocytes | Parenchymal degeneration (%) | Vacuolar degeneration (%) | Necrosis (%) |
---|---|---|---|---|
Control | 56.78±5.41 | 28.91±8.21 | 27.23±4.91 | 12.34±3.72 |
T1 | 55.17±7.14 | 12.23±9.43* | 17.94±5.13 | 16.23±2.73 |
T2 | 25.98±7.54* | 36.13±4.98 | 30.21±6.52 | 47.24±6.74* |
T3 | 15.21±8.95** | 61.13±11.56* | 56.21±7.22* | 32.22±9.32* |
The nano herbal Phaleria macrocarpa can improve the physiology and the histology of the animal test, referring to the phytochemical content of this plant and the improvisation of the particle size to be a nano size. Phaleria macrocarpa fruit chemical composition revealed that the seed shell and flesh fruit of Phaleria macrocarpa obtained flavonoid substances, phenols, saponins, tannins, and sterols/terpenes from herbal extracts of hexane, ethyl acetate, and methanol (
Further, based on our review of the literature, the crude extracts of Phaleria macrocarpa fruit that have been evaluated preclinically in previous studies, obtained by the process of extraction that passed by an excessive heating stage, reached temperatures of more than 60 °C. These techniques can harm the bioactive substances found within them, reducing their effectiveness. These issues can be solved using nanotechnology, which does not use any heating process. Medicinal plants are also suggested because they are less likely to trigger side effects than synthetic medications (
Administration of nano herbal Phaleria macrocarpa dose on chronic toxicity improves the liver, kidneys, lungs, and heart histology. In addition, it improves the body’s physiological function through the parameters of complete blood count, liver and kidney biochemical, and blood electrolytes. The range of doses that do not cause symptoms of chronic damage is 300–600 mg/Kg BW, and the duration of administration does not exceed a month.
The author would like to thank the Ministry of Education for providing financial assistance through the “doctoral dissertation research” program with grant No.3153/E4/KD.00/2021.